Synthesis of 2′-([1,2,3]triazol-1-yl)-2′-deoxyadenosines

Nucleosides, Nucleotides and Nucleic Acids

Volumn 27, Issue 5, 2008, Pages 449-459

  O'Mahony, Gavin ^a   Svensson, Sara ^a   Sundgren, Andreas ^a   Grøtli, Morten ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

3+2 cycloaddition; Nucleoside analogues

Indexed keywords

2' ( 4 HYDROXYMETHYL [1,2,3]TRIAZOL 1 YL) 2' DEOXY 3',5' O (TETRAISOPROPYLDISILOXANE 1,3 DIYL) ADENOSINE PROPIONATE; 2' (4 BUTYL [1,2,3]TRIAZOL 1 YL) 2' DEOXY 3',5' O (TETRAISOPROPYLDISILOXANE 1,3 DIYL) ADENOSINE; 2' (4 BUTYL [1,2,3]TRIAZOL 1 YL) 2' DEOXY ADENOSINE; 2' (4 CARBOETHOXY [1,2,3]TRIAZOL 1 YL) 2' DEOXY 3',5' O (TETRAISOPROPYLDISILOXANE 1,3 DIYL) ADENOSINE; 2' (4 CARBOETHOXY [1,2,3]TRIAZOL 1 YL) 2' DEOXY ADENOSINE; 2' (4 CARBOMETHYL [1,2,3]TRIAZOL 1 YL) 2' DEOXY 3',5' O (TETRAISOPROPYLDISILOXANE 1,3 DIYL0 ADENOSINE; 2' (4 CARBOXYMETHOXY [1,2,3]TRIAZOL 1 YL) 2' DEOXY 3',5' O (TETRAISOPROPYLDISILOXANE 1,3 DIYL) ADENOSINE; 2' (4 CARBOXYMETHYL [1,2,3]TRIAZOL 1 YL) 2' DEOXY ADENOSINE; 2' (4 HYDROXYMETHYL [1,2,3]TRIAZOL 1 YL) 2' DEOXY ADENOSINE; 2' (4 HYDROXYMETHYL [1,2,3]TRIAZOL 1 YL) 2' DEOXY ADENOSINE PROPIONATE; 2' (4 HYDROXYNETHYL [1,2,3]TRIAZOL 1 YL) 2' DEOXY 3',5' O (TETRAISOPROPYLDISILOXANE 1,3 DIYL) ADENOSINE; 2' (4 ISOPROPENYL [1,2,3]TRIAZOL 1 YL) 2' DEOXY 3',5' O (TETRAISOPROPYLDISILOXANE 1,3 DIYL) ADENOSINE; 2' (4 ISOPROPENYL [1,2,3]TRIAZOL 1 YL) 2' DEOXY ADENOSINE; 2' (4 PHENYL [1,2,3]TRIAZOL 1 YL) 2' DEOXY 3',5' O (TETRAISOPROPYLDISILOXANE 1,3 DIYL) ADENOSINE; 2' (4 PHENYL [1,2,3]TRIAZOL 1 YL0 2' DEOXY ADENOSINE; VIDARABINE DERIVATIVE; AMINO ACID TRANSFER RNA LIGASE; DEOXYADENOSINE DERIVATIVE; DRUG DERIVATIVE; ENZYME INHIBITOR; TRIAZOLE DERIVATIVE; VIDARABINE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CYCLOADDITION; DRUG STRUCTURE; DRUG SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

AMINO ACYL-TRNA SYNTHETASES; DEOXYADENOSINES; DRUG DESIGN; ENZYME INHIBITORS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; TRIAZOLES; VIDARABINE;

EID: 45849153115     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770802086880     Document Type: Article

References (27)

1. Nathans, D. 1967. In Antibiotics; eds. D. Gottlieb, P.D Shaw; Springer-Verlag, New York, pp. 259-277.
2. Hamill, R.L.; Nagarajan, R. U.S. Patent 4 087 603;
3. b) Florent, J.; Lunel, J.; Mancy, D. U.S. Patent 4 189 349.
4. De Clercq, E. A guided tour through the antiviral drug field. Future Virology 2006, 1, 19-35.
5. Cheson, B.D.; Keating, M.J.; William Plunkett, W. Nucleoside Analogues in Cancer Therapy; Marcel Dekker, New York, 1997, vol. Nucleoside Analogues in Cancer Therapy.
6. Knapp, S. Synthesis of complex nucleoside antibiotics. Chem. Rev. 1995, 95, 1859-1876.
7. Jacobsen, K.A.; Gau, Z.-G. Adenosine receptors as therapeutic targets. Nature Rev. Drug. Disc. 2006, 5, 247-264.
8. a) Berthert-Colominas, C., Seignovert, L., Ḧartlein, M., Grøtli, M., Cusack, S., Lebermann, R. The crystal structure of asparaginyl-tRNA synthetase from Thermus thermophilus and its complexes with ATP and asparaginyl-adenylate: the mechanism of discrimination between asparagine and aspartic acid. EMBO J. 1998, 17, 2947-2960;
9. b) Yaremchuk, A.; Cusack, S.; Tukalo, M. Crystal structure of a eukaryote/archaeon-like prolyl-tRNA synthetase and its complex with tRNAPro(CGG). EMBO J.. 2000, 19, 4745-4758;
10. c) Yaremchuk, A., Tukalo, M., Grøtli, M., Cusack, S.A Succession of substrate induced conformational changes ensures the amino acid specificity of thermus thermophilus prolyltrna synthetase: Comparison with histidyl-tRNA synthetase. J. Mol. Biol., 2001, 309, 989-1002.
11. O'Mahony, G., Sundgren, A., Svensson, S., Grøtli, M. A practical synthesis of 2′-aminoacylamino-2′-deoxyadenosines. Tetrahedron 2007, 63, 6901-6908.
12. a) Lincecum, T.L., Tukalo, M., Yaremchuk, A., Mursinna, R.S., Williams, A.M., Sproat, B.S., Van Den Eynde, W. Link, A., Van Calenbergh S., Grøtli, M., Martinis S.A., Cusack, S., Structural and mechanistic basis of pre- and posttransfer editing by leucyl-tRNA synthetase. Mol. Cell 2003, 11, 951-963;
13. b) Tukalo, M.; Yaremchuk, A.; Fukunaga, R.; Yokoyama, S.; Cusack, S. The crystal structure of leucyl-tRNA synthetase complexed with tRNALeu in the post-transfer-editing conformation. Nature Struct. Mol. Biol. 2005, 12, 923-930;
14. c) Fukunaga, R.; Yokoyama, S. Structural basis for substrate recognition by the editing domain of isoleucyl-tRNA synthetase. J. Mol. Biol. 2006, 359, 901-912.
15. a) Van Calenbergh, S.; Van Den Eeckhout, E.; Herdewijn, P.; De Bruyn, A.; Verlinde, C.L. M. J.; Hol, W.G. J.; Callens, M.; Van Aerschot, A.; Rozenski, J. Synthesis and conformational analysis of 2′-deoxy-2′-(3- methoxybenzamido)adenosine, a rational-designed inhibitor of trypanosomal glyceraldehyde phosphate dehydrogenase (GAPDH). Helv. Chim. Acta 1994, 77, 631-644;
16. b) Verlinde, C.L.M.J.; Callens, M.; Van Calenbergh, S.; Van Aerschot, A.; Herdewijn, P.; Hannaert, V.; Michels, P.A.; Opperdoes, F.R.; Hol, W.G.J. Selective inhibition of trypanosomal glyceraldehyde-3-phosphate dehydrogenase by protein structure-based design: toward new drugs for the treatment of sleeping sickness. J. Med. Chem. 1994, 37, 3605-3613;
17. c) Van Calenbergh, S.; Verlinde, C.L.M.J.; Soenens, J.; De Bruyn, A.; Callens, M.; Blaton, N.M.; Peeters, O.M.; Rozenski, J.; Hol, W.G.J.; Herdewijn, P. Synthesis and structure-activity relationships of analogs of 2′-deoxy-2′-(3-methoxybenzamido)adenosine, a selective inhibitor of trypanosomal glycosomal glyceraldehyde-3-phosphate dehydrogenase. J. Med. Chem. 1995, 38, 3838-3849;
18. d) Aronov, A.M.; Verlinde, C.L.M.J.; Hol, W.G.J.; Gelb, M.H. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structurebased drug design. J. Med. Chem. 1998, 41, 4790-4799;
19. e) Aronov, A.M.; Suresh, S.; Buckner, F.S.; Van Voorhis, W.C.; Verlinde, C.L.M.J.; Opperdoes, F.R.; Hol, W.G.J.; Gelb, M.H. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 4273-4278;
20. f) Bressi, J.C.; Verlinde, C.L.M.J.; Aronov, A.M.; Shaw, M.L.; Shin, S.S.; Nguyen, L.N.; Suresh, S.; Buckner, F.S.; Van Voorhis, W.C.; Kuntz, I.D.; Hol, W.G.J.; Gelb, M.H. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design, J. Med. Chem. 2001, 44, 2080-2093.
21. a) For reviews on the subject, see: Spatola, A.F. Chemistry and Biochemistry of Amino Acids, Peptides, and Proteins, Marcel Dekker, New York, 1983, pp. 267-357;
22. b) Ahn, J.-M.; Boyle, N.A.; MacDonald, M.T.; Janda, K.D. Peptidomimetics and peptide backbone modifications. Mini-Rev. Med. Chem. 2002, 2, 463-473.
23. a) Rostovtsev, V.V.; Green, L.G.; Fokin, V.V.; Sharpless, K.B. A stepwise Huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes, Angew. Chem., Int. Ed., 2002, 41, 2596-2599;
24. b) Tornoe, C.W.; Christensen, C.; Meldal, M. Peptidotriazoles on Solid Phase: [1,2,3]-Triazoles by Regiospecific Copper(I)-Catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. J. Org. Chem. 2002, 67, 3057-3064.
25. Matulic-Adamic, J.; Beigelman, L.; Dudycz, L.W.; Gonzalez, C.; Usman, N. Synthesis and incorporation of 2′-amino acid conjugated nucleotides into ribozymes. Bioorg. Med. Chem. Lett. 1995, 5, 2721-2724.
26. O'Mahony, G.; Ehrman, E.; Grøtli, M. Synthesis of adenosine-based fluorosides containing a novel heterocyclic ring system. Tetrahedron Lett. 2005, 46, 6745-6748.
27. Zhang, W.J.; Robins, M.J. Nucleic acid related compounds. 72. Removal of silyl protecting groups from hydroxyl functions with ammonium fluoride in methanol. Tetrahedron Lett. 1992, 33, 1177-1180.